--- title: "Medline (MDLN) stock listing, news and investor profile" url: "https://aibio.space/companies/medline/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Medline Inc. (NASDAQ: MDLN), United States. Listing facts, related biotech companies and news on aibio.space." --- MDLN Medline Inc. NASDAQ · United States # Medline (MDLN) news Debt Financing · 2026-05-28 ## [Medline sells $1,250.0 million and $750.0 million in senior secured notes](https://aibio.space/news/medline-sells-1-250-0-million-750-0-million-senior-secured-notes/) Medline issued $1,250.0 million of 2031 notes and $750.0 million of 2033 notes, then refinanced part of its 2030 term loan into an approximately $2,750.0 million loan due 2033. The new debt is secured on substantially all assets. ## Latest Medline news We have not published a story on Medline yet. When there is news, it will appear here. ## Medline at a glance - **Ticker**: MDLN - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 27, 2026**: $2.68 billion ### Related companies - [Enovis CORP](https://aibio.space/companies/enovis/) NYSE: ENOV - [SeaStar Medical Holding](https://aibio.space/companies/seastar-medical/) NASDAQ: ICU - [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO - [BioXcel Therapeutics](https://aibio.space/companies/bioxcel-therapeutics-btaiq/) OTC: BTAIQ - [ICU MEDICAL INC/DE](https://aibio.space/companies/icu-medical-de/) NASDAQ: ICUI - [DENTSPLY SIRONA](https://aibio.space/companies/dentsply-sirona/) NASDAQ: XRAY - [LUDWIG ENTERPRISES, INC.](https://aibio.space/companies/ludwig-enterprises/) OTC: LUDG - [Glass House Brands](https://aibio.space/companies/glass-house-brands/) NYSE: GLAS ### Also on NASDAQ - [PMGC Holdings](https://aibio.space/companies/pmgc/) ELAB - [Rallybio](https://aibio.space/companies/rallybio/) RLYB - [Dogwood Therapeutics](https://aibio.space/companies/dogwood-therapeutics/) DWTX - [TransMedics Group](https://aibio.space/companies/transmedics/) TMDX - [Kura Oncology](https://aibio.space/companies/kura-oncology/) KURA - [Jin Medical International](https://aibio.space/companies/jin-medical-international/) ZJYL ## Medline annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$28.43 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | [$25.51 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | | Research and development | [$80.0 million](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | [$67.0 million](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | | Net income (loss) | [$1.16 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | | | Cash from operations | [$1.74 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | [$1.77 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | | Cash and equivalents | [$1.94 billion](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000051/) | [$199.0 million](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/) | | Short-term investments | [$0](https://www.sec.gov/Archives/edgar/data/2046386/000204638626000051/) | | Latest balance sheet, Jun 27, 2026 (10-Q): cash and equivalents $2.33 billion, plus short-term investments of $350.0 million, $2.68 billion in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Medline What is the ticker symbol of Medline? Medline Inc. trades under the ticker MDLN on NASDAQ. Where is Medline listed? Medline Inc. is listed on NASDAQ. Which country or territory is Medline listed under? Our directory records Medline Inc. under United States. Does aibio.space cover Medline? aibio.space lists Medline Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Medline's revenue last year? $28.43 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Medline profitable? Medline Inc. reported net income of $1.16 billion for the fiscal year ended Dec 31, 2025, and generated $1.74 billion of cash from operations, per its annual report to the SEC. How much does Medline spend on research and development? $80.0 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Medline have? $2.68 billion in cash and short-term investments at Jun 27, 2026, per its 10-Q. What is the latest Medline (MDLN) stock news? Our latest story on Medline, dated May 28, 2026: "Medline sells $1,250.0 million and $750.0 million in senior secured notes". Medline issued $1,250.0 million of 2031 notes and $750.0 million of 2033 notes, then refinanced part of its 2030 term loan into an approximately $2,750.0 million loan due 2033. The new debt is secured on substantially all assets. [Source](https://aibio.space/news/medline-sells-1-250-0-million-750-0-million-senior-secured-notes/). Does Medline have debt, a term loan or convertible notes? Our latest debt story, dated May 28, 2026: "Medline sells $1,250.0 million and $750.0 million in senior secured notes". Medline issued $1,250.0 million of 2031 notes and $750.0 million of 2033 notes, then refinanced part of its 2030 term loan into an approximately $2,750.0 million loan due 2033. The new debt is secured on substantially all assets. [Source](https://aibio.space/news/medline-sells-1-250-0-million-750-0-million-senior-secured-notes/). How can I follow Medline (MDLN) news? Press Follow on this page to add Medline to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Medline so far, in Debt Financing. ## Investor discussion: Medline Members talk about Medline (MDLN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Medline, newest first. Each line links the filing it comes from. 1. 2026-05-26 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/2046386/000119312526239247/d68812d424b4.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:MDLN on TradingView](https://www.tradingview.com/symbols/NASDAQ-MDLN/). ## Listing details Medline Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MDLN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Medline Inc. - **Ticker**: MDLN - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/medline/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Medline (MDLN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/medline/